You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monomethylauristatin E

Showing 1 - 25 of 3,425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Seattle (drug, other,

Recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2022

Recurrent Classic Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Nivolumab)

Recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Nivolumab
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

CD30-Positive Neoplastic Cells Present, Malignant Mesothelioma Trial in Houston (Brentuximab Vedotin, Laboratory Biomarker

Recruiting
  • CD30-Positive Neoplastic Cells Present
  • Malignant Mesothelioma
  • Brentuximab Vedotin
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Jan 3, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Sacramento (Bendamustine Hydrochloride, Brentuximab

Recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Bendamustine Hydrochloride
  • Brentuximab Vedotin
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 17, 2021

Classic Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other,

Active, not recruiting
  • Classic Hodgkin Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • +2 more
  • Duarte, California
  • +5 more
Mar 17, 2022

Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell

Recruiting
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • +13 more
  • Brentuximab Vedotin
  • Pembrolizumab
  • Chicago, Illinois
    Northwestern University
Jun 15, 2022

Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United

Active, not recruiting
Has Results
  • Ann Arbor Stage IB Hodgkin Lymphoma
  • +10 more
  • Brentuximab Vedotin
  • Nivolumab
  • Palo Alto, California
  • +8 more
Jul 20, 2022

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large

Recruiting
  • Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

Active, not recruiting
  • AIDS-Related Hodgkin Lymphoma
  • +11 more
  • Brentuximab Vedotin
  • +4 more
  • La Jolla, California
  • +27 more
Jul 27, 2022

Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular

Recruiting
  • Ann Arbor Stage I Hodgkin Lymphoma
  • +13 more
  • Birmingham, Alabama
  • +16 more
Nov 23, 2021

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Rochester (Brentuximab Vedotin, Everolimus, Laboratory

Terminated
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 10, 2019

Anaplastic Large Cell Lymphoma, ALK-Positive, CD30-Positive Neoplastic Cells Present, Systemic Anaplastic Large Cell Lymphoma

Withdrawn
  • Anaplastic Large Cell Lymphoma, ALK-Positive
  • +2 more
  • Brentuximab Vedotin
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 8, 2019

Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

Active, not recruiting
  • Cutaneous Melanoma
  • +5 more
  • Birmingham, Alabama
  • +13 more
Jan 23, 2023

CD30-Positive Neoplastic Cells Present, Folliculotropic Mycosis Fungoides, Recurrent Mycosis Fungoides Trial in Duarte

Withdrawn
  • CD30-Positive Neoplastic Cells Present
  • +6 more
  • Brentuximab Vedotin
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Apr 26, 2019

Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Refractory Childhood Hodgkin Lymphoma Trial in Canada,

Completed
Has Results
  • Recurrent Adult Hodgkin Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • Gemcitabine Hydrochloride
  • Birmingham, Alabama
  • +115 more
Oct 5, 2021

Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma Trial in

Active, not recruiting
  • Ann Arbor Stage IIB Hodgkin Lymphoma
  • +5 more
  • Bleomycin Sulfate
  • +11 more
  • Birmingham, Alabama
  • +198 more
Sep 16, 2022

Odontogenic Cysts Trial in Buraydah (Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+CS + PO),

Recruiting
  • Odontogenic Cysts
  • Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+CS + PO)
  • +4 more
  • Buraydah, Qassim Region, Saudi Arabia
    College of Dentistry, Qassim University
Nov 13, 2023

Nurse's Role Trial (e-CPD user testing)

Not yet recruiting
  • Nurse's Role
  • e-CPD user testing
  • (no location specified)
Sep 14, 2023

Electronic Cigarette Use, E-Cig Use, Cigarette Smoking Trial in Los Angeles (E-cigarette e-liquid self-administration)

Completed
  • Electronic Cigarette Use
  • +3 more
  • E-cigarette e-liquid self-administration
  • Los Angeles, California
    University of Southern California
Jul 14, 2023

Recurrent Urinary Tract Infection Trial in Helsinki (Feacal microbial transplantation (FMT), Placebo transplantation (PT))

Recruiting
  • Recurrent Urinary Tract Infection
  • Feacal microbial transplantation (FMT)
  • Placebo transplantation (PT)
  • Helsinki, Finland
    Meilahti Vaccine Research Center, Helsinki University Central Ho
Sep 15, 2023

Critically Ill Trial in Amsterdam (Mechanical Insufflation-Exsufflation)

Recruiting
  • Critically Ill
  • Mechanical Insufflation-Exsufflation
  • Amsterdam, Netherlands
    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA
Aug 30, 2023

Perinatal Transmission of MDR Bacteria

Recruiting
  • E. Coli Infection
  • Multi-antibiotic Resistance
    • Chicago, Illinois
      Prentice Women's Hospital
    Nov 20, 2023